Table 2.
Treatment responses and prognosis of the patients
| Steroid response | n (%) |
|---|---|
| Present | 91 (94.8%) |
| Absent | 5 (5.2) |
| Bone marrow examination on the 33rd day | n (%) |
|
| |
| M1 (<5% blast) | 95 (98.9) |
| M2 (5–25% blast) | 1 (1.0) |
| M3 (>25% blast) | 0 (0.0) |
| Prognosis | n (%) |
|
| |
| Complete response | 81 (84.4) |
| Recurrence | 15 (15.6) |
| Bone marrow | 9 (9.4) |
| Testicle | 3 (3.1) |
| CNS | 1 (1.0) |
| Bone marrow and testicle | 1 (1.0) |
| Bone marrow and CNS | 1 (1.0) |
| Second reccurence | 2 (2.0) |
| Mortality | 9 (9.4) |
| Fungal infection | 4 (4.2) |
| Febrile neutropenia | 2 (2.0) |
| Leukemia | 2 (2.0) |
| Secondary tumor (brain tumor) | 1 (1.0) |
CNS: central nervous system